Carcinogenicity Study Protocol Submissions
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 23, 2002
February 1, 2021
1b1fc892-689b-49f0-b1a2-a339b7cf1bd3
Related Documents
Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children
Guidance DocumentMarch 6, 2007Center for Drug Evaluation and Research
Food-Effect Bioavailability and Fed Bioequivalence Studies: Guidance for Industry
Guidance DocumentDecember 1, 2002Center for Drug Evaluation and Research
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.